Recall
FDAHealthJune 30, 2025

Cipla USA, Inc. — Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: C

⚠️ Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
June 30, 2025

Distributed Nationwide in the USA

What's affected?

Product
Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured by: Cipla Ltd. Indore SEZ, Pithampur, India. Manufactured for: Ciple USA, Inc. 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC# 69097-319-86 (pouch), 69097-319-87 (carton)
Lot code
Batch # 4IA0505, Exp 09/31/2026

Additional details

Batch # 4IA0505, Exp 09/31/2026

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 13,680 ampoules.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.